Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Filterlex Medical

Request full access

Filterlex created the CAPTIS® intra-aortic EPD to deflect, capture, and remove embolic particles during TAVI. This new EPD offers full-body protection by trapping and eliminating embolic debris

Yokneam Ilit, IsraelFounded 2015Biotech & Life Sciences

About Filterlex Medical

Developer of an embolic protection device designed to help patients with complications during catheter-based structural heart procedures. The company's device uses next-generation technology to meet the need of current product limitations and weaknesses and is securely positioned in the aorta to provide full-body embolic protection by deflecting, capturing, and removing embolic particles, enabling physicians to reduce the risk of stroke and other complications during catheter-based structural heart procedures.

Source: Dealroom company data

Filterlex Medical in the Yokneam Ilit ecosystem

Live from Dealroom

The Filterlex Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Parnasa VC
  • Alon Medtech Ventures
  • European Innovation Council
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Filterlex Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.